TR199802456T2 - Yeni pirol türevleri. - Google Patents

Yeni pirol türevleri.

Info

Publication number
TR199802456T2
TR199802456T2 TR1998/02456T TR9802456T TR199802456T2 TR 199802456 T2 TR199802456 T2 TR 199802456T2 TR 1998/02456 T TR1998/02456 T TR 1998/02456T TR 9802456 T TR9802456 T TR 9802456T TR 199802456 T2 TR199802456 T2 TR 199802456T2
Authority
TR
Turkey
Prior art keywords
pyrrole derivatives
new pyrrole
formulas
represented
new
Prior art date
Application number
TR1998/02456T
Other languages
English (en)
Inventor
Toscani Galeazzi Edvige
John Kertesz Den�S
Carol Reuter Deborah
Brian Sjogren Eric
Original Assignee
F.Hoffmann-La Roche Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F.Hoffmann-La Roche Ag filed Critical F.Hoffmann-La Roche Ag
Publication of TR199802456T2 publication Critical patent/TR199802456T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/333—Radicals substituted by oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

R10 un, (A), (B) veya (C) formülleri ile temsil edildigi; R20 nini, (U), (V) veya (W) formülleri ile temsil edildigi, Formül I'in bilesikleri ve spesifikasyonlarda tarif edildigi gibi, diger sübstitüentler; ve bunlarin farmasötik olarak kabul edilebilir tuzlari; prostaglandin G/H sentazin inhibitörleri olup, anti enflamatuvar ve analjezik ajanlardir.
TR1998/02456T 1996-05-30 1997-05-21 Yeni pirol türevleri. TR199802456T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1869196P 1996-05-30 1996-05-30

Publications (1)

Publication Number Publication Date
TR199802456T2 true TR199802456T2 (tr) 1999-02-22

Family

ID=21789298

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1998/02456T TR199802456T2 (tr) 1996-05-30 1997-05-21 Yeni pirol türevleri.

Country Status (21)

Country Link
US (3) US5952368A (tr)
EP (1) EP0906279B1 (tr)
JP (1) JP3142581B2 (tr)
KR (1) KR100303377B1 (tr)
CN (1) CN1225629A (tr)
AR (1) AR007297A1 (tr)
AT (1) ATE225333T1 (tr)
AU (1) AU717602B2 (tr)
BR (1) BR9709497A (tr)
CA (1) CA2256609C (tr)
CO (1) CO4960660A1 (tr)
DE (1) DE69716061T2 (tr)
DK (1) DK0906279T3 (tr)
ES (1) ES2182090T3 (tr)
HR (1) HRP970296A2 (tr)
MA (1) MA24346A1 (tr)
PT (1) PT906279E (tr)
TR (1) TR199802456T2 (tr)
TW (1) TW415946B (tr)
WO (1) WO1997046524A1 (tr)
ZA (1) ZA974538B (tr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100793668B1 (ko) 1999-12-08 2008-01-10 파마시아 코포레이션 강화된 생체이용률을 지닌 고체상 형태의 셀레콕시브
AR038957A1 (es) 2001-08-15 2005-02-02 Pharmacia Corp Terapia de combinacion para el tratamiento del cancer
CA2474702A1 (en) * 2002-01-30 2003-08-07 Tularik Inc Heterocyclic arylsulfonamidobenzylic compounds
TWI372050B (en) * 2003-07-03 2012-09-11 Astex Therapeutics Ltd (morpholin-4-ylmethyl-1h-benzimidazol-2-yl)-1h-pyrazoles
WO2005123671A1 (ja) * 2004-06-22 2005-12-29 Taisho Pharmaceutical Co., Ltd. ピロール誘導体
MX2007008008A (es) * 2004-12-30 2007-11-12 Astex Therapeutics Ltd Compuestos de pirazol que modulan la actividad de las cinasas cdk, gsk y aurora.
US8399442B2 (en) * 2005-12-30 2013-03-19 Astex Therapeutics Limited Pharmaceutical compounds
JP5523829B2 (ja) * 2006-06-29 2014-06-18 アステックス、セラピューティックス、リミテッド 複合薬剤
EP2043635A2 (en) * 2006-06-29 2009-04-08 Astex Therapeutics Limited Pharmaceutical combinations
US10358408B2 (en) * 2017-12-22 2019-07-23 Polycarbon Industries, Inc. Synthesis of azelaic acid
IL305573A (en) 2021-03-15 2023-10-01 Saul Yedgar HYALURONIC ACID-CONJUGATED DIPALMITOYL PHOSPHATIDYL ETHANOLAMINE IN COMBINATION WITH NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDs) FOR TREATING OR ALLEVIATING INFLAMMATORY DISEASES

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3752826A (en) * 1970-01-26 1973-08-14 Mcneilab Inc Aroyl substituted pyrroles
US4089969A (en) * 1976-07-14 1978-05-16 Syntex (U.S.A.) Inc. 5-Aroyl-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic acid derivatives and process for the production thereof
ZA825227B (en) * 1981-07-22 1984-03-28 Syntex Inc Substituted pyrrolidine cardiovascular system regulators antihypertensives
IL86462A (en) * 1987-05-29 1992-12-01 Fujisawa Pharmaceutical Co Alkanesulfonanilide derivatives, processes for preparation thereof and pharmaceutical compositions comprising the same
US5622948A (en) * 1994-12-01 1997-04-22 Syntex (U.S.A.) Inc. Pyrrole pyridazine and pyridazinone anti-inflammatory agents

Also Published As

Publication number Publication date
DE69716061D1 (de) 2002-11-07
CA2256609C (en) 2005-07-26
AU3091397A (en) 1998-01-05
KR20000016191A (ko) 2000-03-25
ATE225333T1 (de) 2002-10-15
DE69716061T2 (de) 2003-08-14
TW415946B (en) 2000-12-21
PT906279E (pt) 2003-02-28
ZA974538B (en) 1997-12-01
EP0906279B1 (en) 2002-10-02
HRP970296A2 (en) 1998-04-30
ES2182090T3 (es) 2003-03-01
AR007297A1 (es) 1999-10-27
US6127402A (en) 2000-10-03
BR9709497A (pt) 1999-08-10
KR100303377B1 (ko) 2001-12-12
DK0906279T3 (da) 2003-02-03
JP3142581B2 (ja) 2001-03-07
AU717602B2 (en) 2000-03-30
WO1997046524A1 (en) 1997-12-11
CA2256609A1 (en) 1997-12-11
CN1225629A (zh) 1999-08-11
EP0906279A1 (en) 1999-04-07
US6136844A (en) 2000-10-24
MA24346A1 (fr) 1998-07-01
CO4960660A1 (es) 2000-09-25
JPH11511755A (ja) 1999-10-12
US5952368A (en) 1999-09-14

Similar Documents

Publication Publication Date Title
TR199700419A2 (tr) Yeni piridazinon türevleri.
UY24625A1 (es) Derivados de la 4-hidroxi-piperidina
YU35697A (en) Substituted 6,6-hetero-bicyclic derivatives
IE781788L (en) Thienothiazine
UA35592C2 (uk) Похідні оцтової кислоти
TR199700844T1 (tr) Pirazolil-Benzoil Türevleri.
MX9800804A (es) Derivados de pirrolidina que tienen actividad inhibitoria de la fosfolipasa a2.
ES8703418A1 (es) Un procedimiento para preparar derivados heterociclicos ni- trogenados
TR199802456T2 (tr) Yeni pirol türevleri.
EP0640586A4 (en) STYLE DERIVATIVES AND ANALOGS AND THEIR USE.
DK51087A (da) Antihypercholesterolaemiske forbindelser
MY117092A (en) Chemotherapeutic pyrrolocarbazole derivatives
HRP20000585B1 (en) Substituted bisindolymaleimides for the inhibition of cell proliferation
ES2021182A6 (es) Procedimiento para preparar derivados de capsaicina.
AR003137A1 (es) Una composicion farmaceutica para tratar la leucemia
ES8800122A1 (es) Un procedimiento para la preparacion de derivados de indeno y naftaleno.
DE69625505D1 (de) Guanidino proteiase inhibitoren
HUP9702393A2 (hu) bisz(2-Halogén-etil)-amino-fenil szubsztituált distamycinszármazékok, tumorellenes és vírusellenes hatóanyagok
ATE204846T1 (de) Entzündungshemmende benzoesäurederivate
ES2093091T3 (es) Derivado de glutation.
RU94046387A (ru) Производные пиримидина, способ их получения, фармацевтическая композиция, ее применение и промежуточные продукты
EA199800015A1 (ru) Способ ингибирования меланомы
HRP20010885B1 (en) Ethanesulfonyl-piperidine derivatives
NO933837L (no) 4-aryl-3-(heteroarylureido)kinolin-derivater
UA43338C2 (uk) Похідні бензолу